TY - JOUR T1 - The mass balance model of obesity explains the weight loss advantage of a low-carbohydrate diet over a isocaloric low-fat diet JF - medRxiv DO - 10.1101/2020.10.27.20220202 SP - 2020.10.27.20220202 AU - Anssi H. Manninen AU - Francisco Arencibia-Albite Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/11/2020.10.27.20220202.abstract N2 - Background & Aims There is an ongoing debate about the role of macronutrient distribution of the diet in weight management and the potential of its modification as an approach to treat obesity. Our aim was to shed light on this highly disputed topic.Methods This computational study utilized the recently proposed mass balance model (MBM) of obesity to simulate the effect of exchanging a high-carbohydrate diet (20% F, 65% C, 15% P; HCD) for an isocaloric very-low-carbohydrate diet (75% F, 10% C, 15% P; VLCD) on body weight in a 70kg person. Furthermore, we investigated whether this model can explain the weight loss associated with the onset of type 1 diabetes.Results Prior any feeding perturbation, body weight was stable at ∼70kg with a baseline diet of 2 000 kcal (day 0-149). Next this reference diet was exchange by a 2 000 kcal HCD (day 150-400), yet body weight gradually increases to ∼73kg. Moreover, after beginning a second isocaloric diet but a VLCD (day 400), body weight decreases towards a steady value of ∼67.5kg. In addition, it was demonstrated that the MBM can make predictions of body weight loss consistent with the type 1 diabetes treatment during the pre-insulin era.Conclusions The MBM of obesity explains the weight loss advantage of a low-carbohydrate diet over an isocaloric low-fat diet. In addition, this model explains the weight loss associated with the onset of type I diabetes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a computational study.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A.MBMmass balance modelEBTenergy balance theoryEPMenergy-providing massVLCDvery-low-carbohydrate dietHCDhigh-carbohydrate dietBWbody weightEIenergy intakeT1Dtype 1 diabetesECFextra cellular fluid ER -